News
Hosted on MSN3mon
Iterum Therapeutics Highlights FDA Approval and Market PotentialIterum Therapeutics ((ITRM)) has held its Q4 earnings call. Read on for the main highlights of the call. Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback